Kamila Skwierawska, currently working in Department of Hematology, Oncology and Internal Diseases, The Medical University of Warsaw, Poland. She has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. She has extended her valuable service towards the scientific community with her extensive research work.
|
Plerixafor is a CXCR4 receptor inhibitor,myelom, lymphoma, G-CSF, chemotherapy. |